Cargando…
Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness
PURPOSE: Gemcitabine is the first line and the gold standard drug for pancreatic cancer. However, the anticancer efficacy is severely limited by its instability and poor cellular uptake. To enhance the clinical efficacy of gemcitabine, we constructed a novel nanodrug delivery system based on amphiph...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341456/ https://www.ncbi.nlm.nih.gov/pubmed/35924258 http://dx.doi.org/10.2147/IJN.S371775 |
_version_ | 1784760614327943168 |
---|---|
author | Zhao, Weidong Yang, Shaoyou Li, Chunxiao Li, Feifei Pang, Houjun Xu, Guangling Wang, Yuxin Cong, Mei |
author_facet | Zhao, Weidong Yang, Shaoyou Li, Chunxiao Li, Feifei Pang, Houjun Xu, Guangling Wang, Yuxin Cong, Mei |
author_sort | Zhao, Weidong |
collection | PubMed |
description | PURPOSE: Gemcitabine is the first line and the gold standard drug for pancreatic cancer. However, the anticancer efficacy is severely limited by its instability and poor cellular uptake. To enhance the clinical efficacy of gemcitabine, we constructed a novel nanodrug delivery system based on amphiphilic dendrimers and aliphatic gemcitabine prodrug. METHODS: An aliphatic gemcitabine prodrug and a small amphiphilic dendrimer were synthesized and characterized by high resolution mass spectrometry (HRMS) as well as nuclear magnetic resonance (NMR). Then the aliphatic gemcitabine prodrug was encapsulated into the small amphiphilic dendrimer by film dispersion method, resulting in a novel nanodrug delivery system. Subsequently, the size, morphology, drug loading, stability, drug release profiles, cell uptake, toxicity, the anticancer activity and in vivo distribution of the new developed gemcitabine delivery system were systematically evaluated by different technical methods, including transmission electron microscopy (TEM), dynamic light-scattering (DLS), ultraviolet spectrophotometer, flow cytometry, in vivo imaging system etc. RESULTS: We developed a novel nanodrug delivery system of gemcitabine using amphiphilic dendrimer. This dendrimer-based gemcitabine nanoformulation reported here possess a high drug loading of 33%. With the features of small size, stable formulation and pH-responsive drug release, the obtained gemcitabine nanoformulation could effectively accumulate in tumor site and rapid uptake in cells. Finally, the gemcitabine nanoformulation displayed more potent anticancer activity compared to free gemcitabine both in vitro and in vivo. Moreover, the nanodrug displayed greatly reduced adverse effects and satisfactory biocompatibility. CONCLUSION: Benefiting the advantageous features of both amphiphilic dendrimers and nanotechnology-based drug delivery, this gemcitabine nanosystem constitutes a promising therapeutic candidate for pancreatic cancer treatment. This study also underlines the potential use of self-assembling amphiphilic dendrimer-based nanotechnology for improving drug efficacy as well as reducing drug toxicity. |
format | Online Article Text |
id | pubmed-9341456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93414562022-08-02 Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness Zhao, Weidong Yang, Shaoyou Li, Chunxiao Li, Feifei Pang, Houjun Xu, Guangling Wang, Yuxin Cong, Mei Int J Nanomedicine Original Research PURPOSE: Gemcitabine is the first line and the gold standard drug for pancreatic cancer. However, the anticancer efficacy is severely limited by its instability and poor cellular uptake. To enhance the clinical efficacy of gemcitabine, we constructed a novel nanodrug delivery system based on amphiphilic dendrimers and aliphatic gemcitabine prodrug. METHODS: An aliphatic gemcitabine prodrug and a small amphiphilic dendrimer were synthesized and characterized by high resolution mass spectrometry (HRMS) as well as nuclear magnetic resonance (NMR). Then the aliphatic gemcitabine prodrug was encapsulated into the small amphiphilic dendrimer by film dispersion method, resulting in a novel nanodrug delivery system. Subsequently, the size, morphology, drug loading, stability, drug release profiles, cell uptake, toxicity, the anticancer activity and in vivo distribution of the new developed gemcitabine delivery system were systematically evaluated by different technical methods, including transmission electron microscopy (TEM), dynamic light-scattering (DLS), ultraviolet spectrophotometer, flow cytometry, in vivo imaging system etc. RESULTS: We developed a novel nanodrug delivery system of gemcitabine using amphiphilic dendrimer. This dendrimer-based gemcitabine nanoformulation reported here possess a high drug loading of 33%. With the features of small size, stable formulation and pH-responsive drug release, the obtained gemcitabine nanoformulation could effectively accumulate in tumor site and rapid uptake in cells. Finally, the gemcitabine nanoformulation displayed more potent anticancer activity compared to free gemcitabine both in vitro and in vivo. Moreover, the nanodrug displayed greatly reduced adverse effects and satisfactory biocompatibility. CONCLUSION: Benefiting the advantageous features of both amphiphilic dendrimers and nanotechnology-based drug delivery, this gemcitabine nanosystem constitutes a promising therapeutic candidate for pancreatic cancer treatment. This study also underlines the potential use of self-assembling amphiphilic dendrimer-based nanotechnology for improving drug efficacy as well as reducing drug toxicity. Dove 2022-07-26 /pmc/articles/PMC9341456/ /pubmed/35924258 http://dx.doi.org/10.2147/IJN.S371775 Text en © 2022 Zhao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhao, Weidong Yang, Shaoyou Li, Chunxiao Li, Feifei Pang, Houjun Xu, Guangling Wang, Yuxin Cong, Mei Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title | Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title_full | Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title_fullStr | Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title_full_unstemmed | Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title_short | Amphiphilic Dendritic Nanomicelle-Mediated Delivery of Gemcitabine for Enhancing the Specificity and Effectiveness |
title_sort | amphiphilic dendritic nanomicelle-mediated delivery of gemcitabine for enhancing the specificity and effectiveness |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341456/ https://www.ncbi.nlm.nih.gov/pubmed/35924258 http://dx.doi.org/10.2147/IJN.S371775 |
work_keys_str_mv | AT zhaoweidong amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT yangshaoyou amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT lichunxiao amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT lifeifei amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT panghoujun amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT xuguangling amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT wangyuxin amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness AT congmei amphiphilicdendriticnanomicellemediateddeliveryofgemcitabineforenhancingthespecificityandeffectiveness |